Caring for Children with Dravet Syndrome: Exploring the Daily Challenges of Family Caregivers - Publikacja - MOST Wiedzy

Wyszukiwarka

Caring for Children with Dravet Syndrome: Exploring the Daily Challenges of Family Caregivers

Abstrakt

While Polish studies focus on the symptoms, causes and treatment of people suffering from Dravet syndrome (DS), much less is known about the situation of the family caregivers of DS children. This study was designed to explore the experiences, daily challenges and needs related to caring for DS children. An anonymous self-administered online questionnaire was developed. The
survey was completed by 75 family caregivers affiliated with the Association for People with Severe Refractory Epilepsy DRAVET.PL on Facebook. Most caregivers felt burdened by their children’s reduced mobility (57.3%), mood swings (57.3%), lack of access to rehabilitation and medicine (56%) and healthcare expenses (50.7%). Caregivers also complained of a lack of time to themselves (76%) and work restrictions resulting from caregiving (72%). They consequently reported experiencing fatigue (84%), a deterioration of mental health (60%) and intimacy problems with their spouse/partner (53.4%). An important source of strain was a prolonged diagnostic odyssey and the constant struggle over the healthcare services for DS children. Since DS caregivers’ problems and needs are often overlooked, they may be described as the forgotten people in DS. Healthcare professionals should be educated about the challenges related to caring for DS child, psycho-social status and coping resources of DS caregivers, and should focus on

Cytowania

Autorzy (2)

Cytuj jako

Pełna treść

pobierz publikację
pobrano 5 razy
Wersja publikacji
Submitted Version
Licencja
Creative Commons: CC-BY-NC-ND otwiera się w nowej karcie

Słowa kluczowe

Informacje szczegółowe

Kategoria:
Publikacja w czasopiśmie
Typ:
Publikacja w czasopiśmie
Opublikowano w:
Children-Basel nr 10, wydanie 1410,
ISSN: 2227-9067
Rok wydania:
2023
DOI:
Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) https://doi.org/10.3390/children10081410
Bibliografia: test
  1. Dravet, C. The core Dravet syndrome phenotype. Epilepsia 2011, 52 (Suppl. 2), 3-9. [CrossRef] [PubMed] otwiera się w nowej karcie
  2. Dravet, C. Dravet syndrome history. Dev. Med. Child Neurol. 2011, 53 (Suppl. 2), 1-6. [CrossRef] [PubMed] otwiera się w nowej karcie
  3. Brunklaus, A.; Ellis, R.; Reavey, E.; Forbes, G.H.; Zuberi, S.M. Prognostic, clinical and demographic features in SCN1A mutation- positive Dravet syndrome. Brain 2012, 135 Pt 8, 2329-2336. [CrossRef] otwiera się w nowej karcie
  4. Mei, D.; Cetica, V.; Marini, C.; Guerrini, R. Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies. Epilepsia 2019, 60, S2-S7. [CrossRef] otwiera się w nowej karcie
  5. Scheffer, I.E.; Nabbout, R. SCN1A-related phenotypes: Epilepsy and beyond. Epilepsia 2019, 60, S17-S24. [CrossRef] otwiera się w nowej karcie
  6. Li, W.; Schneider, A.L.; Scheffer, I.E. Defining Dravet syndrome: An essential pre-requisite for precision medicine trials. Epilepsia 2021, 62, 2205-2217. [CrossRef] [PubMed] otwiera się w nowej karcie
  7. Verbeek, N.E.; Wassenaar, M.; van Campen, J.S.; Sonsma, A.; Gunning, B.; Knoers, N.; Lindhout, D.; Jansen, F.E.; Leijten, F.; Brilstra, E.; et al. Seizure precipitants in Dravet syndrome: What events and activities are specifically provocative compared with other epilepsies? Epilepsy Behav. 2015, 47, 39-44. [CrossRef] otwiera się w nowej karcie
  8. Bjurulf, B.; Reilly, C.; Hallböök, T. Caregiver reported seizure precipitants and measures to prevent seizures in children with Dravet syndrome. Seizure 2022, 103, 3-10. [CrossRef] [PubMed] otwiera się w nowej karcie
  9. Lagae, L.; Brambilla, I.; Mingorance, A.; Gibson, E.; Battersby, A. Quality of life and comorbidities associated with Dravet syndrome severity: A multinational cohort survey. Dev. Med. Child Neurol. 2018, 60, 63-72. [CrossRef] otwiera się w nowej karcie
  10. Dravet, C.; Oguni, H. Dravet syndrome (severe myoclonic epilepsy in infancy). Handb. Clin. Neurol. 2013, 111, 627-633. [CrossRef] otwiera się w nowej karcie
  11. Jensen, M.P.; Liljenquist, K.S.; Bocell, F.; Gammaitoni, A.R.; Aron, C.R.; Galer, B.S.; Amtmann, D. Life impact of caregiving for severe childhood epilepsy: Results of expert panels and caregiver focus groups. Epilepsy Behav. 2017, 74, 135-143. [CrossRef] [PubMed] otwiera się w nowej karcie
  12. Nabbout, R.; Auvin, S.; Chiron, C.; Irwin, J.; Mistry, A.; Bonner, N.; Williamson, N.; Bennett, B. Development and content validation of a preliminary core set of patient-and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome. Epilepsy Behav. 2018, 78, 232-242. [CrossRef] [PubMed] otwiera się w nowej karcie
  13. Nabbout, R.; Auvin, S.; Chiron, C.; Thiele, E.; Cross, H.; Scheffer, I.E.; Schneider, A.L.; Guerrini, R.; Williamson, N.; Zogenix and Adelphi Values Study Group. Perception of impact of Dravet syndrome on children and caregivers in multiple countries: Looking beyond seizures. Dev. Med. Child Neurol. 2019, 61, 1229-1236. [CrossRef] [PubMed] otwiera się w nowej karcie
  14. Sullivan, J.; Deighton, A.M.; Vila, M.C.; Szabo, S.M.; Maru, B.; Gofshteyn, J.S.; James, E.S.; Rico, S.; Zuberi, S.M. The clinical, economic, and humanistic burden of Dravet syndrome-A systematic literature review. Epilepsy Behav. 2022, 130, 108661. [CrossRef] otwiera się w nowej karcie
  15. Wallace, A.; Wirrell, E.; Kenney-Jung, D.L. Pharmacotherapy for Dravet syndrome. Paediatr. Drugs 2016, 18, 197-208. [CrossRef] [PubMed] otwiera się w nowej karcie
  16. Strzelczyk, A.; Schubert-Bast, S. Therapeutic advances in Dravet syndrome: A targeted literature review. Expert Rev. Neurother. 2020, 20, 1065-1079. [CrossRef] otwiera się w nowej karcie
  17. Skluzacek, J.V.; Watts, K.P.; Parsy, O.; Wical, B.; Camfield, P. Dravet syndrome and parent associations: The IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief. Epilepsia 2011, 52 (Suppl. 2), 95-101. [CrossRef] otwiera się w nowej karcie
  18. Shmuely, S.; Sisodiya, S.M.; Gunning, W.B.; Sander, J.W.; Thijs, R.D. Mortality in Dravet syndrome: A review. Epilepsy Behav. 2016, 64 Pt A, 69-74. [CrossRef] otwiera się w nowej karcie
  19. Cooper, M.S.; Mcintosh, A.; Crompton, D.E.; McMahon, J.M.; Schneider, A.; Farrell, K.; Ganesan, V.; Gill, D.; Kivity, S.; Lerman-Sagie, T.; et al. Mortality in Dravet syndrome. Epilepsy Res. 2016, 128, 43-47. [CrossRef] otwiera się w nowej karcie
  20. Camfield, P.; Camfield, C.; Nolan, K. Helping families cope with the severe stress of Dravet Syndrome. Can. J. Neurol. Sci. 2016, 43 (Suppl. 3), S9-S12. [CrossRef] otwiera się w nowej karcie
  21. Jensen, M.P.; Brunklaus, A.; Dorris, L.; Zuberi, S.M.; Knupp, K.G.; Galer, B.S.; Gammaitoni, A.R. The humanistic and economic burden of Dravet syndrome on caregivers and families: Implications for future research. Epilepsy Behav. 2017, 70 Pt A, 104-109. [CrossRef] otwiera się w nowej karcie
  22. Campbell, J.D.; Whittington, M.D.; Kim, C.H.; VanderVeen, G.R.; Knupp, K.G.; Gammaitoni, A. Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver survey. Epilepsy Behav. 2018, 80, 152-156. [CrossRef] [PubMed] otwiera się w nowej karcie
  23. Whittington, M.D.; Knupp, K.G.; Vanderveen, G.; Kim, C.; Gammaitoni, A.; Campbell, J.D. The direct and indirect costs of Dravet Syndrome. Epilepsy Behav. 2018, 80, 109-113. [CrossRef] otwiera się w nowej karcie
  24. Lagae, L.; Irwin, J.; Gibson, E.; Battersby, A. Caregiver impact and health service use in high and low severity Dravet syndrome: A multinational cohort study. Seizure 2019, 65, 72-79. [CrossRef] [PubMed] otwiera się w nowej karcie
  25. Strzelczyk, A.; Schubert-Bast, S.; Bast, T.; Bettendorf, U.; Fiedler, B.; Hamer, H.M.; Herting, A.; Kalski, M.; Kay, L.; Kieslich, M.; et al. A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany. Epilepsia 2019, 60, 1697-1710. [CrossRef] [PubMed] otwiera się w nowej karcie
  26. Strzelczyk, A.; Kalski, M.; Bast, T.; Wiemer-Kruel, A.; Bettendorf, U.; Kay, L.; Kieslich, M.; Kluger, G.; Kurlemann, G.; Mayer, T.; et al. Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from Germany. Eur. J. Paediatr. Neurol. 2019, 23, 392-403. [CrossRef] otwiera się w nowej karcie
  27. Aledo-Serrano, A.; Mingorance, A. Análisis del impacto familiar y necesidades del síndrome de Dravet en España. Rev. Neurol. 2020, 70, 75-83. [CrossRef] otwiera się w nowej karcie
  28. Nabbout, R.; Dirani, M.; Teng, T.; Bianic, F.; Martin, M.; Holland, R.; Chemaly, N.; Coque, N. Impact of childhood Dravet syndrome on care givers of patients with DS, a major impact on mothers. Epilepsy Behav. 2020, 108, 107094. [CrossRef] otwiera się w nowej karcie
  29. Juandó-Prats, C.; James, E.; Bilder, D.A.; McNair, L.; Kenneally, N.; Helfer, J.; Huang, N.; Vila, M.C.; Sullivan, J.; Wirrell, E.; et al. DRAVET ENGAGE. Parent caregivers of children with Dravet syndrome: Perspectives, needs, and opportunities for clinical research. Epilepsy Behav. 2021, 122, 108198. [CrossRef] otwiera się w nowej karcie
  30. Hoffman-Zacharska, D.; Szczepanik, E.; Terczynska, I.; Goszczanska-Ciuchta, A.; Zalewska-Miszkurka, Z.; Tataj, R.; Bal, J. From focal epilepsy to Dravet syndrome-Heterogeneity of the phenotype due to SCN1A mutations of the p.Arg1596 amino acid residue in the Nav1.1 subunit. Neurol. Neurochir. Pol. 2015, 49, 258-266. [CrossRef] otwiera się w nowej karcie
  31. Paprocka, J.; Lewandowska, A.; Zieliński, P.; Kurczab, B.; Emich-Widera, E.; Mazurczak, T. Dravet Syndrome-The Polish Family's Perspective Study. J. Clin. Med. 2021, 10, 1903. [CrossRef] [PubMed] otwiera się w nowej karcie
  32. Eurostat; otwiera się w nowej karcie
  33. Brancato, G.; Macchia, S.; Murgia, M.; Signore, M.; Simeoni, G.; Blanke, K.; Körner, T.; Nimmergut, A.; Lima, P.; et al. The Handbook of Recommended Practices for Questionnaire Development and Testing in the European Statistical System. 2005. Available online: https://unstats.un.org/unsd/EconStatKB/KnowledgebaseArticle10364.aspx (accessed on 1 March 2023).
  34. Domaradzki, J.; Walkowiak, D. Emotional experiences of family caregivers of children with Dravet syndrome. Epilepsy Behav. 2023, 142, 109193. [CrossRef] [PubMed] otwiera się w nowej karcie
  35. Patel, A.D.; Arya, A.; Agarwal, V.; Gupta, P.K.; Agarwal, M. Burden of care and quality of life in caregivers of children and adolescents with autism spectrum disorder. Asian J. Psychiatr. 2022, 70, 103030. [CrossRef] [PubMed] otwiera się w nowej karcie
  36. Ten Hoopen, L.W.; de Nijs, P.F.A.; Duvekot, J.; Greaves-Lord, K.; Hillegers, M.H.J.; Brouwer, W.B.F.; Hakkaart-van Roijen, L. Caring for children with an Autism Spectrum Disorder: Factors associating with health-and care-related quality of life of the caregivers. J. Autism Dev. Disord. 2022, 52, 4665-4678. [CrossRef] otwiera się w nowej karcie
  37. Aubeeluck, A.V.; Buchanan, H.; Stupple, E.J. 'All the burden on all the carers': Exploring quality of life with family caregivers of Huntington's disease patients. Qual. Life Res. 2012, 21, 1425-1435. [CrossRef] otwiera się w nowej karcie
  38. Domaradzki, J. The impact of Huntington disease on family carers: A literature overview. Psychiatr. Pol. 2015, 49, 931-944. [CrossRef] otwiera się w nowej karcie
  39. Weisman, O.; Feldman, R.; Burg-Malki, M.; Keren, M.; Geva, R.; Diesendruck, G.; Gothelf, D. Mother-child interaction as a window to a unique social phenotype in 22q11.2 deletion syndrome and in Williams syndrome. J. Autism Dev. Dis. 2015, 45, 2567-2577. [CrossRef] otwiera się w nowej karcie
  40. Scallan, S.; Senior, J.; Reilly, C. Williams syndrome: Daily challenges and positive impact on the family. J. Appl. Res. Intellect. Disabil. 2011, 24, 181-188. [CrossRef] otwiera się w nowej karcie
  41. Sarimski, K. Behavioural phenotypes and family stress in three mental retardation syndromes. Eur. Child Adolesc. Psychiatry 1997, 6, 26-31. [CrossRef] otwiera się w nowej karcie
  42. Reilly, C.; Murtagh, L.; Senior, J. The impact on the family of four neurogenetic syndromes: A comparative study of parental views. J. Genet. Couns. 2015, 24, 851-861. [CrossRef] otwiera się w nowej karcie
  43. Ashworth, M.; Palikara, O.; Van Herwegen, J. Comparing parental stress of children with neurodevelopmental disorders: The case of Williams syndrome, Down syndrome and autism spectrum disorders. J. Appl. Res. Intellect. Disabil. 2019, 32, 1047-1057. [CrossRef] [PubMed] otwiera się w nowej karcie
  44. Sandilands, K.; Williams, A.; Rylands, A.J. Carer burden in rare inherited diseases: A literature review and conceptual model. Orphanet J. Rare Dis. 2022, 17, 428. [CrossRef] [PubMed] otwiera się w nowej karcie
  45. Mcmullan, J.; Lohfeld, L.; McKnight, A.J. Needs of informal caregivers of people with a rare disease: A rapid review of the literature. BMJ Open 2022, 12, e063263. [CrossRef] [PubMed] otwiera się w nowej karcie
  46. Smits, R.M.; Vissers, E.; te Pas, R.; Roebbers, N.; Feitz, W.F.J.; van Rooij, I.A.L.M.; de Blaauw, I.; Verhaak, C.M. Common needs in uncommon conditions: A qualitative study to explore the need for care in pediatric patients with rare diseases. Orphanet J. Rare Dis. 2022, 17, 153. [CrossRef] otwiera się w nowej karcie
  47. Nolan, K.J.; Camfield, C.S.; Camfield, P.R. Coping with Dravet syndrome: Parental experiences with a catastrophic epilepsy. Dev. Med. Child Neurol. 2006, 48, 761-765. [CrossRef] otwiera się w nowej karcie
  48. Nolan, K.; Camfield, C.S.; Camfield, P.R. Coping with a child with Dravet syndrome: Insights from families. J. Child Neurol. 2008, 23, 690-694. [CrossRef] [PubMed] otwiera się w nowej karcie
  49. Desnous, B.; Goujon, E.; Bellavoine, V.; Merdariu, D.; Auvin, S. Perceptions of fever and fever management practices in parents of children with Dravet syndrome. Epilepsy Behav. 2011, 21, 446-448. [CrossRef] otwiera się w nowej karcie
  50. Udwin, O.; Howlin, P.; Davies, M.; Mannion, E. Community care for adults with Williams syndrome: How families cope and the availability of support networks. J. Appl. Res. Intellect. Disabil. 1998, 42 Pt 3, 238-245. [CrossRef] otwiera się w nowej karcie
  51. Serur, Y.; Sher-Censor, E.; Sofrin-Frumer, D.; Daon, K.; Sobol-Havia, D.; Weinberger, R.; Shulman, C.; Gothelf, D. Parental expressed emotion, parenting stress, and behavioral problems of young children with 22q11.2 deletion syndrome and idiopathic Autism Spectrum Disorder. Child Psychiatry Hum. Dev. 2023, 54, 1085-1093. [CrossRef] otwiera się w nowej karcie
  52. Riechmann, J.; Strzelczyk, A.; Reese, J.P.; Boor, R.; Stephani, U.; Langner, C.; Neubauer, B.A.; Oberman, B.; Philippi, H.; Rochel, M.; et al. Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany. Epilepsia 2015, 56, 1388-1397. [CrossRef] otwiera się w nowej karcie
  53. Strzelczyk, A.; Schubert-Bast, S.; Reese, J.P.; Rosenow, F.; Stephani, U.; Boor, R. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam. Epilepsy Behav. 2014, 34, 86-91. [CrossRef] [PubMed] otwiera się w nowej karcie
  54. Rizzo, R.; Van den Bree, M.; Challenger, A.; Cuthbert, A.; Ayllon, M.A.; Clarke, A.; Thompson, R. Co-creating a knowledge base in the "22q11.2 deletion syndrome" community. J. Community Genet. 2020, 11, 101-111. [CrossRef] [PubMed] otwiera się w nowej karcie
  55. Irwin, J.; Lagae, L.; Gibson, E.; Battersby, A. Health service use in high and low severity Dravet syndrome in the EU5. Value Health 2018, 21, S342. [CrossRef] otwiera się w nowej karcie
  56. Domaradzki, J. Family caregivers' experiences with healthcare services: A case of Huntington disease. Psychiatr. Pol. 2016, 50, 375-391. [CrossRef] [PubMed] otwiera się w nowej karcie
  57. Teutsch, S.; Zurynski, Y.; Eslick, G.D.; Deverell, M.; Christodoulou, J.; Leonard, H.; Dalkeith, T.; Johnson, S.L.J.; Elliott, E.J. Australian children living with rare diseases: Health service use and barriers to accessing care. World J. Pediatr. 2023, 19, 701-709. [CrossRef] [PubMed] otwiera się w nowej karcie
  58. Anderson, M.; Elliott, E.J.; Zurynski, Y.A. Australian families living with rare disease: Experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J. Rare Dis. 2013, 8, 22. [CrossRef] [PubMed] otwiera się w nowej karcie
  59. Carmichael, N.; Tsipis, J.; Windmueller, G.; Mandel, L.; Estrella, E. "Is it going to hurt?": The impact of the diagnostic odyssey on children and their families. J. Genet. Couns. 2015, 24, 325-335. [CrossRef] otwiera się w nowej karcie
  60. Llubes-Arrià, L.; Sanromà-Ortíz, M.; Torné-Ruiz, A.; Carillo-Álvarez, E.; García-Expósito, J.; Roca, J. Emotional experience of the diagnostic process of a rare disease and the perception of support systems: A scoping review. J. Clin. Nurs. 2022, 31, 20-31. [CrossRef] otwiera się w nowej karcie
  61. Silvennoinen, K.; Puvirajasinghe, C.; Hudgell, K.; Sidhu, M.K.; Martins Custodio, H.; Genomics England Research Consor- tium; otwiera się w nowej karcie
  62. Jones, W.D.; Balestrini, S.; Sisodiya, S.M. Late diagnoses of Dravet syndrome: How many individuals are we missing? Epilepsia Open 2021, 6, 770-776. [CrossRef] otwiera się w nowej karcie
  63. Walkowiak, D.; Domaradzki, J. Needs assessment study of rare diseases education for nurses and nursing students in Poland. Orphanet J. Rare Dis. 2020, 15, 167. [CrossRef] [PubMed] otwiera się w nowej karcie
  64. Walkowiak, D.; Domaradzki, J. Are rare diseases overlooked by medical education? Awareness of rare diseases among physicians in Poland: An explanatory study. Orphanet J. Rare Dis. 2021, 16, 400. [CrossRef] [PubMed] otwiera się w nowej karcie
  65. Domaradzki, J.; Walkowiak, D. Knowledge and attitudes of future healthcare professionals towards rare diseases. Front. Genet. 2021, 12, 639610. [CrossRef] [PubMed] otwiera się w nowej karcie
  66. Baumbusch, J.; Mayer, S.; Sloan-Yip, I. Alone in a crowd? Parents of children with rare diseases' experiences of navigating the healthcare System. J. Genet. Couns. 2019, 28, 80-90. [CrossRef] [PubMed] otwiera się w nowej karcie
  67. O'Donoghue, E.; McAllister, M.; Rizzo, R. The experiences of families receiving a diagnosis of 22q11.2 deletion syndrome in Ireland. J. Genet. Couns. 2023, 32, 618-634. [CrossRef] otwiera się w nowej karcie
  68. Ramaglia, G.; Romeo, A.; Viri, M.; Lodi, M.; Sacchi, S.; Cioffi, G. Impact of idiopathic epilepsy on mothers and fathers: Strain, burden of care, worries and perception of vulnerability. Epilepsia 2007, 48, 1810-1814. [CrossRef] otwiera się w nowej karcie
  69. Ferro, M.A.; Speechley, K.N. What about dads? An exploratory analysis of depressive symptoms in paternal primary caregivers of children with epilepsy. Epilepsy Behav. 2012, 23, 90-91. [CrossRef] otwiera się w nowej karcie
  70. Disclaimer/Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Weryfikacja:
Brak weryfikacji

wyświetlono 34 razy

Publikacje, które mogą cię zainteresować

Meta Tagi